Welcome to
Sysmex Flow Cytometry Other European Country!

For ordering please make sure you are in your local shop.
If you are from Other European Country then please continue.
Otherwise please go to your country.

Go to my country Continue

Article successfully added.

CyFlow™ CD95 PE

CyFlow™ CD95 PE
Antigen: CD95
Alternative Name: APO-1, Fas, TNFRSF6
Clone: LT95
Application: Flow cytometry
Format/Fluorochrome: PE
Laser: Blue, Green, Yellow
Target Species: Human
Field of Interest: Apoptosis, Immunophenotyping
Species of Origin: Mouse
Regulatory Status: RUO
Clonality: monoclonal
Emission Maximum: 576 nm
Excitation Maximum: 496 nm, 565 nm
Isotype: IgG1
Order number: CT982494

For Research Use Only
Not for use in diagnostic or therapeutic procedures.

Quantity 100 tests Volume 2 Immunogen HUT-78 human T cell lymphoma cell line... more
CyFlow™ CD95 PE
Quantity100 tests
Volume2
ImmunogenHUT-78 human T cell lymphoma cell line
Background InformationCD95 (Fas, APO-1), a 46 kDa transmembrane glycoprotein, is a cell death receptor of the TNFR superfamily. Stimulation of CD95 results in aggregation of its intracellular death domains, formation of the death-inducing signaling complex (DISC) and activation of caspases. In type I cells caspase 3 is activated by high amounts of caspase 8 generated at the DISC, in type II cells low concentration of caspase 8 activates pathway leading to the release of cytochrome c from mitochondria and activation of caspase 3 by cytochom c. Besides its roles in induction of apoptosis, Fas also triggers pro-inflammatory cytokine responses.
UsageThe reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 20·µl reagent·/ 100·µl of whole blood or 10^6 cells in a suspension. The content of a vial (2 ml) is sufficient for 100 tests.
Storage BufferThe reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.

Specific References

| Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME: Two CD95 (APO‑1/Fas) signaling pathways. EMBO·J. 1998·Mar·16; 17(6):1675‑87. <·PMID:·9501089·> | Park DR, Thomsen AR, Frevert CW, Pham U, Skerrett SJ, Kiener PA, Liles WC: Fas (CD95 induces proinflammatory cytokine responses by human monocytes and monocyte‑derived macrophages. J·Immunol. 2003·Jun·15; 170(12):6209‑16. <·PMID:·12794152·> | Drosopoulos KG, Roberts ML, Cermak L, Sasazuki T, Shirasawa S, Andera L, Pintzas A: Transformation by oncogenic RAS sensitizes human colon cells to TRAIL‑induced apoptosis by up‑regulating death receptor 4 and death receptor 5 through a MEK‑dependent pathway. J·Biol·Chem. 2005·Jun·179 dec; 280(24):22856‑67. <·PMID:·15757891·> | Guo Z, Zhang M, Tang H, Cao X: Fas signal links innate and adaptive immunity by promoting dendritic‑cell secretion of CC and CXC chemokines. Blood. 2005·Sep·15; 106(6):2033‑41. <·PMID:·15941911·> | Brumatti G, Yon M, Castro FA, Bueno-da-Silva AE, Jacysyn JF, Brunner T, Amarante-Mendes GP: Conversion of CD95 (Fas) Type II into Type I signaling by sub‑lethal doses of cycloheximide. Exp·Cell·Res. 2008·Feb·1; 314(3):554‑63. <·PMID:·18078929·>